In our cohort, the presence of an IDH2 mutation did not correlate with the presence of PTEN , P53 , and ATRX mutations, but a highly significant positive correlation was observed with the presence of a 1p/19q co-deletion: 44.4 % of IDH2 mutation patients harbored a 1p/19q co-deletion.
← all excerpts
The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.
1
—
—